Literature DB >> 18710797

Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls.

Atmaram Yarlagadda, Badalin Helvink, Caroline Chou, Kenneth Gladieux, Adrienne Keller, Anita Clayton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18710797     DOI： 10.1016/j.schres.2008.06.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  The blood brain barrier and the role of ratiometric molecular analysis in schizophrenia.

Authors:  Atmaram Yarlagadda; Christiane S Hampe; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2010-12

2.  GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitus.

Authors:  Atmaram Yarlagadda; Jerome H Taylor; Christiane S Hampe; Elizabeth Alfson; Anita H Clayton
Journal:  Innov Clin Neurosci       Date:  2011-08

3.  The blood brain barrier and the role of cytokines in neuropsychiatry.

Authors:  Atmaram Yarlagadda; Elizabeth Alfson; Anita H Clayton
Journal:  Psychiatry (Edgmont)       Date:  2009-11

4.  Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach.

Authors:  Niels Hansen; Michael Lipp; Jonathan Vogelgsang; Ruth Vukovich; Tristan Zindler; Daniel Luedecke; Stefan Gingele; Berend Malchow; Helge Frieling; Simone Kühn; Johannes Denk; Jürgen Gallinat; Thomas Skripuletz; Nicole Moschny; Jens Fiehler; Christian Riedel; Klaus Wiedemann; Mike P Wattjes; Inga Zerr; Hermann Esselmann; Stefan Bleich; Jens Wiltfang; Alexandra Neyazi
Journal:  Brain Behav Immun Health       Date:  2020-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.